Companies Continue Betting on Prediction Markets Amid Regulatory Uncertainty NRx Pharmaceuticals Attracts Analyst Attention With Buy Rating and Ketamine Market Ambitions Social Security Timing Dilemma Claim Now or Wait for Survivor Benefits at 67 Treasury Yield Surge Prompts Bond Investors to Seek Better Opportunities in Intermediates BBBs and High Yield You Dont Have to Suffer Tori Dunlap Advocates for Balanced Debt Repayment Over WhiteKnuckling SpaceX Scrubs Starship Test Flight Targets Friday for Debut of Upgraded V3 Rocket AutoZone Stock Suffers Worst Day in Four Years Despite Earnings Beat